Trials / Withdrawn
WithdrawnNCT02295787
Intranasal Ketamine for Late-Life Depression and Suicidal Ideation
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The investigators of this study plan to investigate the feasibility and efficacy of repeated doses of intranasal ketamine in severely depressed patients who are at least 65 years of age and experiencing suicidal ideation. The results of the study could lead to development of new strategies for treating depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine | Intranasal ketamine for late-life depression and suicidal ideation. |
| DRUG | Placebo |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2014-11-20
- Last updated
- 2017-03-03
Source: ClinicalTrials.gov record NCT02295787. Inclusion in this directory is not an endorsement.